Hepatic triglyceride lipase (HTGL) and lipoprotein lipase (LPL) probably have major roles in the removal of triglyceride from triglyceride-rich lipoproteins and in the formation of high density lipoprotein (HDL). However, no population-based study of their activity and relationship to lipoprotein lipid levels has been reported. To determine these relationships, we recalled 33 men and 17 women of a randomly selected sample of the Lipid Research Clinics Pacific Northwest Bell Telephone Company Health Survey. The subjects were 53 ± 7 years old (mean ± SD) with total triglyceride levels of 120 ± 57 mg/dl and total cholesterol levels of 224 ± 35 mg/dl. Postheparin plasma LPL activity (127 ± 61 nmol/min/ml) was not significantly correlated with either age, sex, or adiposity. In contrast, HTGL activity was significantly higher in men (235 ± 84 nmol/ min/ml) than women (170 ± 91 nmol/min/ml, p < 0.02), and was correlated with age in men and with adiposity in women. In both men and women, HTGL activity was related positively with VLDL triglyceride and inversely with HDL 2 cholesterol. When the association between HTGL activity and VLDL triglyceride was examined with values from men and women pooled, the relationship was not weakened after adjustment for the linear effect of sex, adiposity, LPL, or HDL 2 cholesterol. H eparin releases into plasma two enzymes, hepatic triglyceride lipase (HTGL) and lipoprotein lipase (LPL). The two lipases can be distinguished in postheparin plasma by the requirement of LPL for apolipoprotein (apo) C-ll, 1 by the inhibition of LPL by NaCI and protamine sulfate, 2 by the different elution characteristics of these lipases from heparin-Sepharose, 3 and by selective inhibition by specific antibodies. 45 HTGL originates from the liver and is thought to function in removing triglyceride (TG) from very low density lipoprotein (VLDL) and other particles of decreasing size.
H eparin releases into plasma two enzymes, hepatic triglyceride lipase (HTGL) and lipoprotein lipase (LPL). The two lipases can be distinguished in postheparin plasma by the requirement of LPL for apolipoprotein (apo) C-ll, 1 by the inhibition of LPL by NaCI and protamine sulfate, 2 by the different elution characteristics of these lipases from heparin-Sepharose, 3 and by selective inhibition by specific antibodies. 45 HTGL originates from the liver and is thought to function in removing triglyceride (TG) from very low density lipoprotein (VLDL) and other particles of decreasing size. 67 Consistent with this pro-posal, patients lacking HTGL activity have an abnormal VLDL, R-VLDL, pre-B-VLDL in their plasma and elevated TG levels in both low density lipoprotein (LDL) and high density lipoprotein (HDL). 8 LPL originates from extrahepatic tissues and is thought to function mainly in the removal of TG from chylomicrons. 9 Patients lacking LPL have chylomicronemia, but do not have (3-VLDL or elevated levels of TG in either LDL or HDL. 1011 Both HTGL and LPL have reportedly correlated with HDL cholesterol levels 12 ' 13 and specifically with the HDL 2 subtraction. 14 ' 15 They differ, however, in that HTGL correlates negatively, while LPL correlates positively. An inverse relationship exists between HDL and the risk of ischemic heart disease in many studies. 1617 Because low HDL, cholesterol is associated with atherosclerosis (determined by coronary angiography) 18 and HDL 2 cholesterol is decreased in survivors of myocardial infarction, 19 it is important to understand how HTGL and LPL relate to HDL metabolism.
We examined a random sample of men and women from the Pacific Northwest Bell Telephone Company Health Survey 20 ' 21 for the behavioral correlates of the HDL subtractions. 22 We also obtained postheparin plasma from these subjects, and in the current report we describe the associations between postheparin plasma HTGL and LPL and lipoprotein lipids.
Methods

Population Sample
All subjects were from a 2% random sample of 5000 participants in the Pacific Northwest Bell Telephone Company Health Survey, 2021 which was conducted by the Northwest Lipid Research Clinic under the auspices of the Population Studies component of the Lipid Research Clinics Program. 23 Only individuals who 1) were over age 30 at the time of the initial screening, 2) were still living in the Greater Seattle area, and 3) had agreed to participate in a yearly follow-up were invited to participate in the current study. Of the original sample, 20 were under the age of 30 at the original screening (between 1972 and 1974) four had moved out of the area, seven refused further contact, and two had died; this left 67 possible participants. There were 50 subjects (aged 38 to 65) who gave informed consent for the current study; this was a response rate of 75%. This visit (the fourth for these subjects) took place in May and June, 1981. The project was approved by the University of Washington Human Subjects Review Committee.
Study Protocol
The clinic visit included administration of a questionnaire covering demographic information, menopausal status, medication use, smoking (number of cigarettes presently smoked) and drinking (frequency of alcohol use). Subjects were instructed to fast for 12 to 14 hours before coming to the clinic, where they were weighed without shoes, jackets, or coats. Their height was measured without shoes. Body mass index (BMI) was determined by dividing weight (kg) by height squared (m 2 ).
Laboratory Methods
Antecubital venous blood was drawn through a 21 -gauge butterfly infusion kit and mixed immediately with dry disodium EDTA (1.5 mg/ml blood) in a vacutainer tube (Becton Dickinson and Company, Rutherford, New Jersey). Heparin (10 units/kg, Upjohn Company, Kalamazoo, Michigan) was injected, followed by 10 ml of 0.9% sterile saline to flush the line. Blood was drawn 10 minutes after the heparin injection, was mixed with EDTA in a similar vacutainer tube, and was placed in ice. Blood was promptly centrifuged at 1500 g for 30 minutes at 4° C, and the resulting plasma was collected. The postheparin plasma was frozen and stored at -20° C for assay.
The lipoproteins were isolated from the preheparin plasma by ultracentrifugation and heparin-manganese precipitation by the standard laboratory protocol of the Lipid Research Clinics. 24 The preheparin plasma was also used to measure the cholesterol in the HDL subclasses with the two-step precipitation method of Gidez et al. 25 The first precipitation was performed with heparin (40,000 U/ml, Riker Laboratories, Northridge, California) and MnCI 2 , and the procedure yielded HDL. The second precipitation was performed with dextran sulfate (15,000 daltons, Sochibo SA, Boulogne, France) and yielded HDL3. The cholesterol in these supernatant fractions was measured by standard Lipid Research Clinics methodology. 24 After correction for dilution, the HDL, cholesterol was calculated as the difference between HDL cholesterol and HDL3 cholesterol. Lipoproteins and subfractions were analyzed within 72 hours.
HTGL and LPL were measured within 1 month after the clinic visit by using a modification of the method of Huttunen et al. 26 Both substrates contained, per milliliter, glycerol trioleate (2.9 /i.mol), glyceryl tri [1 - l4 C]oleate(0.13/xCi), gumarabic(10 mg), and bovine serum albumin (20 mg). The substrate for total postheparin plasma TG lipase activity contained serum (0.1 ml) and a low salt concentration (0.2 M NaCI, 0.5 ml), whereas that for HTGL contained 0.9% NaCI (0.1 ml) in place of the serum and a high salt concentration (2 M NaCI, 0.5 ml). The assays were run at 28° C for 90 minutes. The released 14 C fatty acids were extracted as described by Belfrage and Vaughan. 27 LPL activity was calculated by subtracting the HTGL activity from the total activity.
HTGL measured by this procedure was found to correlate closely with the level measured by heparinSepharose chromatography (r 3 = 0.980, p < 0.001) by the method of Applebaum et al., 28 which used Triton X-100 instead of gum arabic. 12 The level of LPL measured by this procedure did not correlate with the level obtained with heparin-Sepharose chromatography. Since this lack of agreement may have been due to a low recovery of LPL from the chromatography step, the modified assay of Huttunen et al. 26 was chosen for the current study.
Statistical Methods
Statistical analyses are based on the entire sample of men and women after ensuring that the inclusion of either the one nonwhite woman or the nine subjects on antihypertensive drugs did not alter the results. Descriptive statistics including the mean, standard deviation (SD), and median (50th percentile) are given separately for men and women. The Wilcoxon rank sum test statistic 29 was used to determine significant differences in HTGL and LPL between men and women. Relationships between two variables were estimated by using Spearman's rank correlation coefficient (rj with a corresponding test of significance. 30 First-order Pearson correlation coefficients were used to measure the association between two variables after the linear effects of a third variable had been removed. To obtain normal distributions, we performed logarithmic transformations on VLDL-TG and HDL, cholesterol. In addition, we performed stepwise multiple linear regression to adjust for effects which proved to be significant in univariate analysis. Caution should be used in the interpretation of probability values (p) due to the small sample and because multiple testing increases the risk of obtaining a significant result purely by chance. 
Characteristics of the Study Subjects
The 50 subjects who participated in this study ranged in age from 38 to 65 years, with the men (n = 33) having a median age of 52 years and the women (n = 17) having a median age of 55 years ( Table 1) . The men had a higher body mass index (BMI) (median = 27.5) than the women (median = 24.1, p = 0.02). Of the men, 33% were cigarette smokers and 76% consumed more than one alcoholic drink per week. Of the women, 18% smoked cigarettes and 35% consumed more than one alcoholic beverage per week. The mean and median plasma lipid and lipoprotein levels for the population are presented in Table 1 . The men had higher levels of VLDL cholesterol (p < 0.01), and VLDL-TG (p < 0.05) but lower levels of HDL cholesterol (p < 0.01), HDL-TG (p < 0.05), and HDL, cholesterol (p < 0.01) than the women. The levels of LDL cholesterol and LDL-TG were similar in both men and women. We have recently reported a detailed analysis of the effects of smoking, alcohol, and adiposity on the HDL subtractions, apolipoproteins, and lecithin cholesterol acyltransferase. 22 
Results
HTGL activity was normally distributed in men and ranged from 89 to 447 nmol/min/ml, with a mean of 235 ± 84 nmol/min/ml (median, 237) ( Figure 1 ). HTGL activity levels were not normally distributed in women, and ranged from 56 to 254 nmol/min/ml plus one value at 424 nmol/min/ml with a median value of 166, which was significantly lower than in men (p = 0.02). Of the 12 postmenopausal women, the four oldest were taking replacement hormones. The woman taking depotestadiol, an androgenic sex steroid, had the highest HTGL activity found in a woman ( Table 2 ). The three women taking postmenopausal estrogens (mainly natural conjugated estrogens, Prematin) had a mean HTGL activity of 169 ± 94 nmol/min/ml (median, 185). HTGL activity for the 13 women not taking sex steroids was 150 ± 59 nmol/min/ml (range, 56 to 252 nmol/min/ml; median, 154), and when these women were categorized as to pre-and postmenopausal status, the five premenopausal females were found to have HTGL activity levels similar to those of the eight postmenopausal women. LPL activity was normally distributed in both men and women (Figure 1 ). LPL activity appeared to be lower in men (117 + 61 nmol/min/ml) than in women (149 ± 57 nmol/min/ml), although the difference was not statistically significant. The woman taking depotestadiol had the lowest level of LPL activity (52 nmol/min/ml) ( Table 2 ). The LPL activity in women taking estrogens was 132 ± 2 nmol/min/ml. The LPL activity in women not taking sex steroids was 160 ± 58 nmol/min/ml. Premenopausal women had LPL levels similar to those of postmenopausal women.
Spearman rank correlations between age, BMI, lipoprotein lipid levels, and the activities of the TG lipases are shown in Table 3 . HTGL activity was negatively correlated with age in men (r s = -0.36, p = 0.02) and positively, but not quite significantly, correlated with age in women (r s = 0.32, p = 0.106). Thus, the difference between men and women decreased with age. Although HTGL activity was not significantly correlated with BMI in men, it was highly correlated with BMI in women (r s = 0.67, p = 0.001) (Figure 2 ), and this relationship still existed when the women taking sex steroids were removed from the analysis (r s = 0.60, n = 13, p = 0.014). In contrast to the relationships seen with HTGL activity, LPL activity was not significantly correlated with age or BMI in men or women. HTGL appeared to be negatively correlated with LPL in men and women, but the relationship was not statistically significant (p > 0.05). Neither HTGL nor LPL was related to cigarette smoking or alcohol consumption in either men or women.
HTGL activity was significantly positively correlated with VLDL-TG in men (r s = 0.38, p = 0.014) and women (r s = 0.74, p = 0.001) (Figure 3) . HTGL was negatively correlated with HDLj cholesterol in men (r 3 = -0.35, p = 0.022) and in women (r 3 = -0.50, p = 0.02) (Figure 4) . In men, HTGL activity also was correlated negatively with LDL-TG (r s = -0.31, p = 0.04) and HDL-TG (r s = -0.39, p = 0.01). In women, the correlation coefficient for the relationship between HTGL and HDL-TG was similar to that in men, but was not statistically significant, perhaps because of the smaller number of women in our sample. When the women taking sex steroids were removed from the analysis, HTGL was still significantly positively correlated with VLDL-TG (r s = 0.66, n = 13, p = 0.007), but the relationship with HDL, cholesterol was not significant (r s = -0.28, n = 13, p = 0.18), possibly due to truncating the range of HDL, cholesterol. LPL activity was not highly related to lipoprotein lipid levels, but was negatively related Partial correlation coefficients between the HTGL and VLDL-TG and HDL, cholesterol were obtained. In this analysis, the gender-specific data were pooled (n = 50) and the logarithms of VLDL-TG and HDL, cholesterol were used. HTGL activity was normally distributed when the values from men and women were pooled. The strong relation between HTGL activity and log VLDL-TG (simple r = 0.508) was not considerably weakened (r = 0.385 to 0.465) after adjustment for the linear effect of sex, BMI, LPL, or log HDL, cholesterol. In contrast, the partial correlation coefficient between HTGL and log HDL, cholesterol (simple r = -0.326) was considerably weakened by either BMI (r = -0.149) or log VLDL-TG (r = -0.188).
To examine further the difference in the interrelationships between the TG lipases and lipoprotein lipids, the data were analyzed by stepwise multiple regression (Table 4) . With HTGL activity as the dependent variable, the correlation was strongest with log VLDL-TG and was entered into the regression equation before HDL-TG, LDL-TG, BMI, LPL activity, and sex. When stepwise multiple regression was performed with HTGL as the dependent variable and with log HDLj cholesterol, but not HDL-TG or LDL-TG, less variability in HTGL activity was explained (42% vs 64%). 
Discussion
In contrast to earlier reports which measured activity, 62631 the current study was designed to determine the relationships between postheparin plasma HTGL activity and lipoprotein lipids in a well-defined population. Due to the relatively small sample size, caution should be used in interpreting the probability values. Nevertheless, the mean HTGL values reported here are almost identical to those found by Krauss et al. 6 in a larger sample of normal volunteers aged 19 to 62 years (Table 5 ). Greten et al. 31 reported HTGL levels about one-third of the activity in the current study. When Huttunen et al. 28 used a higher heparin dose, they obtained HTGL levels about twice that reported here. However, regardless of the absolute values, all four studies showed lower HTGL levels in women. Postheparin plasma LPL levels were not found to be statistically different in men versus women in the current study, nor in two of the other studies, but were higher in women in the report of Huttunen et al. Like HTGL, the levels of LPL activity differed among the studies and were highest at the higher heparin dose.
We have previously examined the effect of sex steroids on HTGL levels and found that ethinyl estradiol administration was associated with lower HTGL levels, 28 while androgen (stanozoiol) administration was associated with higher HTGL levels. 32 Another androgenic steroid, oxandrolone, also has been reported to increase HTGL levels. 33 If endogenous sex steroids were to act similarly to the exogenous ones, they might be responsible for the observed lower HTGL activity in women versus men. Furthermore, a sex steroid-related difference would be expected to decrease with age such as that shown for HTGL. Although the effects of Premarin on HTGL activity have not been studied, we would have predicted that, like ethinyl estradiol, it would decrease HTGL activity. In contrast to this prediction, HTGL activity in the women taking Premarin was similar to that in women not taking postmenopausal estrogens. This similarity in HTGL activity may be due to Premarin having a much lower potency than ethinyl estradiol. Alternatively, it may be that Premarin did lower the activity and that without Premarin the activity would have been even higher (due to decreasing endogenous estrogens with age). If the latter is true, the failure to find a significant relationship between HTGL activity and age in women in our current study and in that of Huttunen et al. might be due to the tendency to treat older postmenopausal women with estrogens.
HTGL levels have been reportedly higher in male smokers 34 and alcoholics. 35 In the current study, neither HTGL nor LPL levels were significantly related to smoking or alcohol consumption. It is tempting to suggest that one reason for the apparent difference in the data of smokers is related to the populations studied. Kuusi et al. 34 examined a group of young, very physically fit men (military academy students) living under strictly comparable conditions, whereas our population consisted of older men and women in a much more diverse environment. We did, however, find that another enzyme related to HDL cholesterol metabolism, lecithin-cholesterol acyltransferase, was lower in the smokers in our population. 2136 We have previously shown a negative correlation between HTGL activity and HDL cholesterol levels in nromal men. 12 In the current study, HTGL levels were significantly negatively related with the levels of HDL, cholesterol, but not with total HDL cholesterol or HDL3 cholesterol. Similarly, Kuusi et al.
14 found a negative correlation between HTGL levels and HDLj cholesterol but not HDL, cholesterol. VLDL-TG levels have reportedly been inversely related to HDL cholesterol levels, 37 -38 but neither of these earlier studies controlled for VLDL-TG. In the current study, HTGL activity was significantly positively correlated with VLDL-TG levels. Since VLDL-TG also was correlated with BMI and HDLj cholesterol, we examined the effect of controlling for these variables. Although the positive correlation between HTGL activity and VLDL-TG levels was not diminished significantly by controlling for either BMI or HDL-, cholesterol, the relationship between HTGL activity and HDL, cholesterol was considerably weakened after controlling for either BMI or VLDL-TG. Thus, the relationship between HTGL and VLDL-TG appeared to be inde-pendent of BMI or HDL, cholesterol, but the relationship with HDL, cholesterol was not independent of BMI or VLDL-TG.
If the assay overestimated HTGL activity, it would underestimate lipoprotein lipase and there would be an inverse relationship. Thus, the inverse relationship between HTGL and LPL levels may be due to the fact that LPL was estimated by difference. Nevertheless, LPL levels tended to be inversely related to VLDL-TG levels in the current study as we described earlier. 2839 Further evidence of this relationship was evident in the negative correlation with VLDL cholesterol. This inverse relationship is consistent with LPL playing a rate-limiting role in VLDL catabolism.
The positive correlation between HTGL activity and VLDL-TG levels in this report appears to present a paradox. If HTGL removes TG from VLDL, it should be negatively related to VLDL-TG. The positive relationship suggests that in contrast to LPL, HTGL does not have a strong role in VLDL-TG catabolism. Consistent with these findings, Huttunen et al. 26 and Reardon et al. 40 have examined HTGL levels and VLDL metabolism and found no evidence that HTGL played a rate-limiting role in the catabolism of TGrich lipoproteins when LPL activity was normal. However, patients lacking LPL (Type I hyperlipoproteinemia) frequently have normal or only slightly elevated VLDL levels. 41 When Nicoll and Lewis 42 studied VLDL apo B conversion in these patients, they found that it was normal, as was HTGL activity against VLDL. Furthermore, at equal lipoprotein TG concentrations, HTGL had increasing activity with lipoproteins of decreasing particle size. Thus, Nicoll and Lewis calculated that the mean contribution of HTGL to VLDL-TG hydrolysis by postheparin plasma was 35% in normal controls, but to intermediate density lipoprotein-TG, hydrolysis was up to 58%. This conclusion is supported by the fact that two brothers who had no HTGL did have abnormal VLDL ((3-VLDL), and increased levels of TG in LDL and HDL. 8 Krauss et al. 6 and Musliner et al. 7 have examined the ability of HTGL to hydrolyze lipoprotein lipids in vitro. They both found that HTGL hydrolyzes TG from VLDL 2 to 7 times better than from chylomicrons, although LPL still hydrolyzed VLDL-TG more avidly than did HTGL. Musliner et al. also showed that HTGL was better able to hydrolyze LDL-TG and HDL-TG than was LPL. HTGL, in contrast to LPL, could release a small amount of fatty acid from TGrich HDL, but LPL could not. These in vitro studies are consistent with the results of the stepwise multiple regression analysis performed in the current study, where HDL-TG and LDL-TG were quite strongly inversely related to HTGL activity, but not to LPL activity. In the studies by Musliner et al. fatty acid released by HTGL was from TG, not from phospholipids, and they suggested that in severe hypertriglyceridemia, where TG may replace cholesterol ester as the predominant neutral lipid in LDL and HDL, the role of HTGL may be even more important. Thus, the in vitro studies complement the in vivo ones and support the suggestion that human HTGL is probably important in catabolism of VLDL-remnants, IDL, LDL, and HDL, and may only be important in VLDL catabolism when LPL is abnormal.
